{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:76136"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:76136","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Understanding Somatic Mosaicism in Myotonic Dystrophy Type 1","abstract":"Myotonic dystrophy type 1 is caused by an unstable CTG repeat expansion in the 3' UTR of the DM1 protein kinase gene on chromosome 19. A neuromuscular disease with a broad spectrum of symptoms, DM1 also exhibits anticipation whereby disease severity increases through successive generations. Increasing measured allele size between patients correlates with an increased severity of symptoms and an earlier age of onset. However, this correlation is not precise and therefore measured allele length caimot be used as an accurate indicator of age of onset. This suggests that repeat length may not be the major determinant of disease severity. There is a high level of somatic mosaicism shown by the mutation and failure to take into account age-dependent somatic mosaicism in patients may have compromised the accuracy of clinical correlations. The aim of this project was to investigate simple approaches for correcting for age-dependent somatic mosaicism and also to develop computer software to allow us to simulate the progression of age-dependent somatic mosaicism. We have demonstrated that employing alternative approaches in both molecular diagnoses and statistical comparison can yield significantly improved repeat length / age of onset correlations. This conclusively shows that repeat length is by far the major determinant in DM1 disease onset. Simulation software was also successfully developed and preliminary results suggest that DM1 repeat instability is amenable to mathematical modelling in the future.","abstract_html":"Myotonic dystrophy type 1 is caused by an unstable CTG repeat expansion in the 3&#x27; UTR of the DM1 protein kinase gene on chromosome 19. A neuromuscular disease with a broad spectrum of symptoms, DM1 also exhibits anticipation whereby disease severity increases through successive generations. Increasing measured allele size between patients correlates with an increased severity of symptoms and an earlier age of onset. However, this correlation is not precise and therefore measured allele length caimot be used as an accurate indicator of age of onset. This suggests that repeat length may not be the major determinant of disease severity. There is a high level of somatic mosaicism shown by the mutation and failure to take into account age-dependent somatic mosaicism in patients may have compromised the accuracy of clinical correlations. The aim of this project was to investigate simple approaches for correcting for age-dependent somatic mosaicism and also to develop computer software to allow us to simulate the progression of age-dependent somatic mosaicism. We have demonstrated that employing alternative approaches in both molecular diagnoses and statistical comparison can yield significantly improved repeat length / age of onset correlations. This conclusively shows that repeat length is by far the major determinant in DM1 disease onset. Simulation software was also successfully developed and preliminary results suggest that DM1 repeat instability is amenable to mathematical modelling in the future.","abstract_has_math":false,"creators":["Hogg, Grant Fraser"],"institution":"University of Glasgow","degree_name":null,"degree_level":"MSc(R)","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2000,"date_issued":"2000","date_published":"2000","updated_at":"2026-11-19T08:31:00Z","subjects":[],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://theses.gla.ac.uk/76136/1/13818947.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A76136","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Hogg, Grant Fraser"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2000"]},{"key":"dc:date.issued","label":"Date","values":["2000"]},{"key":"dc:publisher.commercial","label":"Dc Publisher Commercial","values":["ProQuest Dissertations & Theses,"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Department not provided."]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/76136/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["MSc(R)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/76136/1/13818947.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Myotonic dystrophy type 1 is caused by an unstable CTG repeat expansion in the 3' UTR of the DM1 protein kinase gene on chromosome 19. A neuromuscular disease with a broad spectrum of symptoms, DM1 also exhibits anticipation whereby disease severity increases through successive generations. Increasing measured allele size between patients correlates with an increased severity of symptoms and an earlier age of onset. However, this correlation is not precise and therefore measured allele length caimot be used as an accurate indicator of age of onset. This suggests that repeat length may not be the major determinant of disease severity. There is a high level of somatic mosaicism shown by the mutation and failure to take into account age-dependent somatic mosaicism in patients may have compromised the accuracy of clinical correlations. The aim of this project was to investigate simple approaches for correcting for age-dependent somatic mosaicism and also to develop computer software to allow us to simulate the progression of age-dependent somatic mosaicism. We have demonstrated that employing alternative approaches in both molecular diagnoses and statistical comparison can yield significantly improved repeat length / age of onset correlations. This conclusively shows that repeat length is by far the major determinant in DM1 disease onset. Simulation software was also successfully developed and preliminary results suggest that DM1 repeat instability is amenable to mathematical modelling in the future."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Understanding Somatic Mosaicism in Myotonic Dystrophy Type 1"]}]}],"canonical_facts":{"dc:creator":["Hogg, Grant Fraser"],"dc:date":["2000"],"dc:date.issued":["2000"],"dc:description.abstract":["Myotonic dystrophy type 1 is caused by an unstable CTG repeat expansion in the 3' UTR of the DM1 protein kinase gene on chromosome 19. A neuromuscular disease with a broad spectrum of symptoms, DM1 also exhibits anticipation whereby disease severity increases through successive generations. Increasing measured allele size between patients correlates with an increased severity of symptoms and an earlier age of onset. However, this correlation is not precise and therefore measured allele length caimot be used as an accurate indicator of age of onset. This suggests that repeat length may not be the major determinant of disease severity. There is a high level of somatic mosaicism shown by the mutation and failure to take into account age-dependent somatic mosaicism in patients may have compromised the accuracy of clinical correlations. The aim of this project was to investigate simple approaches for correcting for age-dependent somatic mosaicism and also to develop computer software to allow us to simulate the progression of age-dependent somatic mosaicism. We have demonstrated that employing alternative approaches in both molecular diagnoses and statistical comparison can yield significantly improved repeat length / age of onset correlations. This conclusively shows that repeat length is by far the major determinant in DM1 disease onset. Simulation software was also successfully developed and preliminary results suggest that DM1 repeat instability is amenable to mathematical modelling in the future."],"dc:format":["application/pdf"],"dc:identifier.uri":["https://theses.gla.ac.uk/76136/1/13818947.pdf"],"dc:language":["en"],"dc:publisher.commercial":["ProQuest Dissertations & Theses,"],"dc:publisher.department":["Department not provided."],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/76136/"],"dcterms:accessrights":["public"],"dc:title":["Understanding Somatic Mosaicism in Myotonic Dystrophy Type 1"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["MSc(R)"]},"updated_at":"2026-11-19T08:31:00Z"}